NATD1

Across TCGA pan-cancer cohorts, NATD1 mass-spec protein is linked to patient survival in 1 of 34 cancer types, making it a survival-associated NATD1 data layer compared with 25 for mass-spec protein and 2 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher NATD1 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated NATD1 expression acts as an unfavorable survival marker, although some lineages such as LUAD show a favorable association.

LUAD are the cancer types where NATD1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	All	1.000	0.772	.002	20	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

NATD1–LUAD (OS)

Open the LUAD breakdown →